We selected the commercially-available osteosarcoma cell line SaOS-2/ALT+ and two in-house derived sarcoma cell lines: the LB188/ALT+ rhabdomyosarcoma cell line [21] and the LB857/ALT+ myxoid sarcoma cell line [22]. This evidence concerns the gene GPT and osteosarcoma.